Identification of potential pharmacological and toxicological targets differentiating structural analogs by a combination of transcriptional profiling and promoter analysis in LS-180 and Caco-2 adenocarcinoma cell lines.

Source:http://linkedlifedata.com/resource/pubmed/id/16847427

Download in:

View as

General Info

PMID
16847427